"A cancer diagnosis can be the most overwhelming experience a person may ever face, and we know that diagnosis is just the beginning of a challenging journey to successfully fight this disease," said Ann Marie Pomerinke, CEO of the American Cancer Society Great West Division. "While there are many uncertainties associated with cancer, the Patient Navigator Program can relieve some of these anxieties by providing personalized support and education for the needs of each patient and their families."
Navigators for the American Cancer Society's Patient Navigator Program provide patients, survivors, and caregivers with social services and programs, as well as resources tailored to the local community. As no cancer experience is the same, navigators also are equipped to provide patients with customized, high-quality, current, easy-to-understand cancer-related information. Navigators seek to improve quality of life for cancer patients, families and caregivers throughout the continuum -- from time of diagnosis, through treatment, into survivorship. Furthermore, navigators are able to increase treatment compliance and follow-up care through a greater understanding of issues.
"AstraZeneca is thrilled to be the first corporation to give nationwide, large-scale support to the American Cancer Society's Patient Navigator Program," said Lisa Schoenberg, Vice President of Specialty Care, AstraZeneca LP. "This is the beginning of a new chapter in AstraZeneca's commitment to personalized cancer care. We are proud to support the American Cancer Society's Patient Navigator Program in its mission of improving patient outcomes, not only in Washington, but in communities throughout the country."
"Successfully treating cancer involves more than accurate diagnosis and
effective therapies," said Jean McMahon, executive director Providence
Regional Cancer Partnership. "We must tend to the whole patient experience
Copyright©2007 PR Newswire.
All rights reserved